Ampicillin News and Research

RSS

New study reveals cefoxitin as effective first-line treatment for intraamniotic infections

The effectiveness of Cefoxitin in the treatment of Endometritis and Intraamniotic Infections (IAI).

5 Feb 2024

International research collaboration leads to breakthrough in antibiotic resistance testing using DNA sequencing

The accuracy of antibiotic resistance determination from Enterococcus faecium genomes for diagnostic purposes.

15 Jan 2024

Gut microbiota linked to social anxiety behaviors

Study reveals that gut microbiota from individuals with social anxiety disorder (SAD) can induce social fear behaviors in mice, suggesting a causal role of gut microbes in modulating behaviors relevant to SAD.

2 Jan 2024

Green tea-silver nanoparticles: A promising weapon against superbugs

Once upon a time, people believed to be invincible against bacterial diseases, thanks to the antibiotics. Does this sound like a fairy tale? By all means! Nothing could be further from the truth.

17 Nov 2023

Promising potential of probiotics and their byproducts for targeting antibiotic-resistant bacteria

The use of probiotics and antimicrobial peptides (AMPs) against multi-drug-resistant (MDR) bacteria.

27 Sep 2023

Trends in antibiotic usage among inpatients in South America during COVID-19 pandemic

Researchers evaluate how the COVID-19 pandemic impacted antibiotic use in healthcare facilities throughout South America.

12 Jul 2023

Escherichia coli ST2797 as a novel emerging extended-spectrum beta-lactamase Escherichia coli

Researchers suggest that Escherichia coli ST2797 could potentially be a new type of extended-spectrum beta-lactamase (ESBL) Escherichia coli.

5 Jun 2023

New clinical trial gets underway to evaluate new antibiotic combinations for newborns with sepsis

An international clinical trial to evaluate much-needed new antibiotic combinations for newborn babies with sepsis has started in three public hospitals in South Africa and Kenya.

22 May 2023

New and efficient technique for rapid antibiotic susceptibility testing using optical microscopy

Researchers at EPFL and Vrije Universiteit Brussel have developed a novel and highly efficient method for rapid antibiotic susceptibility testing using optical microscopy.

24 Apr 2023

The international spread of drug-resistant Shigella sonnei

Researchers examined the international dissemination of the outbreak of extensively drug-resistant Shigella sonnei.

12 Apr 2023

Study explores the association between gut microbiome dysbiosis and uveitis

Researchers provide an overview of existing research on the correlation between uveitis and gut dysbiosis.

7 Apr 2023

The burden of Clostridioides difficile infections in the United States

Researchers review existing data on Clostridioides difficile infections among United States residents.

13 Mar 2023

Researchers discover new transporter used by some bacteria to recycle cell wall fragments

A transporter which some bacteria use to recycle fragments of their cell wall has been discovered by researchers at Umeå university, Sweden.

26 Jan 2023

New research finds community interactions drive antibiotic tolerance in bacteria

In a new study, researchers examined the evolutionary trajectory of a lab-grown community of bacterium, Escherichia coli, having two interacting strains.

17 Jan 2023

Researchers study bacterial co-infections and antibiotic use in COVID-19 patients

Researchers estimated the frequency of bacterial co-infections among hospitalized coronavirus disease 2019 (COVID-19) patients and of antibiotic prescriptions in the initial COVID-19 period for appraising the usage of antibiotic stewardship criteria.

13 Jan 2023

Trends in antibiotic resistance for the priority bacterial pathogens in children and adults

Researchers assessed the variation in antibiotic resistance patterns in adults and children.

5 Jan 2023

The incidence of antimicrobial resistance among urinary E. coli isolates is increasing in both hospital and community settings in Australia

Researchers comparatively evaluated trends in AMR among urinary Escherichia coli strains from a private, commercial community-based laboratory and a public HB laboratory in the Illawarra Shoalhaven area located in NSW, Australia.

1 Dec 2022